Treatment Updates for Alzheimer’s Disease: Some Hope for Prevention

October 1, 2021

Dr. Michael Fulks comments on the results of a recent study of Donanemab, an antibody that targets the amyloid-β (Aβ)… Read More

Tags: Alzheimers, Cardiovascular, Dementia, Risk